Quality of Life in Breast Cancer Patients using Neoadjuvant AC (Doxorubicin and Cyclophosphamide) in Comparison with PG (Paclitaxel and Gemcitabine) Therapy

Background: Quality of life has become a part of the evaluation criteria for cancer therapy. The aim of this study was to evaluate the quality of life in breast cancer patients under chemotherapy regimens that contained doxorubicin and cyclophosphamide (AC) compared to paclitaxel and gemcitabine...

Full description

Bibliographic Details
Main Authors: Aziz Rezapour, Javad Javan-Noughabi, Ahmad Faramarzi, Touraj Harati Khalilabad, Sajjad Vahedi, Abedin Teymourizad
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2018-01-01
Series:Middle East Journal of Cancer
Subjects:
Online Access:http://mejc.sums.ac.ir/index.php/mejc/article/view/507/340